Doctor Ashkan Shoamanesh
McMaster University, Hamilton (Canada)
PACIFIC-STROKE - Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study.
Event: ESC Congress 2022
Topic: Prevention
Session: HOT LINE SESSION 5
ESC 365 is supported by
